Search Results - "Naja, Meena"

A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases by de Gruijter, Nina M, Naja, Meena, Peckham, Hannah, Radziszewska, Anna, Kinsella, Matthew, Glenister, James, Rosser, Elizabeth C, Butler, Gary E, Jury, Elizabeth C, Ciurtin, Coziana

“…Autoimmune rheumatic diseases (ARDs) are associated with a significant sex-bias, which becomes more evident post-puberty. This systematic review aims to…”
Get full text

COVID-19 infection in children and adolescents by Naja, Meena, Wedderburn, Lucy, Ciurtin, Coziana

“…The COVID-19 pandemic has predominantly affected the adult population. The disease is less well-defined in children (≤18 years). This review summarises the…”
Get full text

P069 Results of an online survey exploring the effects of shielding during the COVID-19 pandemic on patients with spondyloarthritis (SpA) by Naja, Meena, Amarnani, Raj, Castelino, Madhura

“…Abstract Background/Aims  The COVID-19 pandemic has created many challenges for patients with chronic rheumatological diseases. SpA - which includes ankylosing…”
Get full text

P283 Clinical predictors of switching biologic treatment in patients PsA: data from a single centre over 17 years by Naja, Meena, Santos, Liliana R, Greenwood, Mandy, Castelino, Madhura

“…Abstract Background Management of PsA has included biologic agents (bDMARDs) since the early 2000s, in addition to conventional disease-modifying antirheumatic…”
Get full text

P282 Outcome for PsA biologic switchers following primary inefficacy of TNFi therapy in a secondary care cohort: sequential TNFi versus switching mode of action by Naja, Meena, Santos, Liliana R, Shipa, Muhammad, Mandy, Greenwood, Castelino, Madhura

“…Abstract Background TNFi are the most used first line of biologic disease modifying anti-rheumatic drugs (bDMARDs) in PsA. In primary loss of response (PLR) to…”
Get full text

P243 Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and early relapse in patients undergoing treatment for systemic lupus erythematosus by Wincup, Chris, Dunn, Nicky, Ruetsch-Chelli, Caroline, Manouchehrinia, Ali, Kharlamova, Nastya, Naja, Meena, Seitz-Polski, Barbara, Isenberg, David, Fogdell-Hahn, Anna, Ciurtin, Coziana, Jury, Elizabeth

“…Abstract Background/Aims A major limitation of biologic therapy is formation of anti-drug antibodies (ADA). We previously demonstrated that ADA to rituximab…”
Get full text

Stratification of Patients With Sjögren’s Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications by Martin‐Gutierrez, Lucia, Peng, Junjie, Thompson, Nicolyn L., Robinson, George A., Naja, Meena, Peckham, Hannah, Wu, WingHan, J’bari, Hajar, Ahwireng, Nyarko, Waddington, Kirsty E., Bradford, Claire M., Varnier, Giulia, Gandhi, Akash, Radmore, Rebecca, Gupta, Vivek, Isenberg, David A., Jury, Elizabeth C., Ciurtin, Coziana

“…Objective Similarities in the clinical and laboratory features of primary Sjögren’s syndrome (SS) and systemic lupus erythematosus (SLE) have led to attempts…”
Get full text

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus by Wincup, Chris, Dunn, Nicky, Ruetsch-Chelli, Caroline, Manouchehrinia, Ali, Kharlamova, Nastya, Naja, Meena, Seitz-Polski, Barbara, Isenberg, David A, Fogdell-Hahn, Anna, Ciurtin, Coziana, Jury, Elizabeth C

“…Abstract Objectives High rates of anti-drug antibodies (ADA) to rituximab have been demonstrated in patients undergoing treatment for SLE. However, little is…”
Get full text

A Comparison of Long-Term Outcomes in Patients Managed With Venovenous Extracorporeal Membrane Oxygenation in the First and Second Waves of the COVID-19 Pandemic in the United Kingdom by Garfield, Benjamin E., Bianchi, Paolo, Arachchillage, Deepa J., Caetano, Francisca, Desai, Sujal, Doyle, James, Hernandez Caballero, Clara, Doyle, Anne-Marie, Mehta, Sachin, Law, Alexander, Jaggar, Sian, Kokosi, Maria, Molyneaux, Philip L., Passariello, Maurizio, Naja, Meena, Ridge, Carole, Alçada, Joana, Patel, Brijesh, Singh, Suveer, Ledot, Stephane

Get full text

A Comparison of Long-Term Outcomes in Patients Managed With Venovenous Extracorporeal Membrane Oxygenation in the First and Second Waves of the COVID-19 Pandemic in the United Kingdom by Garfield, Benjamin E., Bianchi, Paolo, Arachchillage, Deepa J., Caetano, Francisca, Desai, Sujal, Doyle, James, Hernandez Caballero, Clara, Doyle, Anne-Marie, Mehta, Sachin, Law, Alexander, Jaggar, Sian, Kokosi, Maria, Molyneaux, Philip L., Passariello, Maurizio, Naja, Meena, Ridge, Carole, Alçada, Joana, Patel, Brijesh, Singh, Suveer, Ledot, Stephane

“…Early studies of venovenous extracorporeal membrane oxygenation (ECMO) in COVID-19 have revealed similar outcomes to historical cohorts. Changes in the disease…”
Get full text

EP35 What do patients with lupus know about cardiovascular risk: could dietary modification be a promising therapeutic? by Robinson, George A, Navarro, Elvira Chocano, Waddington, Kirsty, Mcdonnell, Thomas, Wincup, Chris, Martin-Gutierrez, Lucia, Maggio, Annalisa, McLoughlin, Eve, Rosser, Lizzy, Naja, Meena, Isenberg, David A, Kalea, Anastasia Z, Ciurtin, Coziana, Pineda-Torra, Ines, Jury, Elizabeth C

“…Abstract Background Cardiovascular disease is the leading cause of mortality for patients with lupus. Understanding increased cardiovascular risk (CVR) in…”
Get full text

Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE by Robinson, George A., Waddington, Kirsty E., Coelewij, Leda, Peng, Junjie, Naja, Meena, Wincup, Chris, Radziszewska, Anna, Peckham, Hannah, Isenberg, David A., Ioannou, Yiannis, Ciurtin, Coziana, Pineda-Torra, Ines, Jury, Elizabeth C.

“…Cardiovascular disease is a leading cause of mortality in patients with juvenile-onset systemic lupus erythematosus (JSLE). Traditional factors for…”
Get full text

P36 Using machine learning to identify and stratify patients with juvenile-onset SLE by Robinson, George, Peng, Junjie, Radziszewska, Anna, Wincup, Chris, Peckham, Hannah, Naja, Meena, Isenberg, David, Ioannou, Yiannis, Pineda-Torra, Ines, Ciurtin, Coziana, Jury, Elizabeth

“…BackgroundJuvenile-onset Systemic Lupus Erythematosus (JSLE) is a complex disease characterised by diagnosis and treatment delays. We applied a machine…”
Get full text

Two shared immune cell signatures stratify patients with Sjögren's syndrome and systemic lupus erythematosus with potential therapeutic implications by Martin-Gutierrez, Lucia, Peng, Junjie, Thompson, Nicolyn L, Robinson, George A, Naja, Meena, Peckham, Hannah, Wu, WingHan, J'bari, Hajar, Ahwireng, Nyarko, Waddington, Kirsty E, Bradford, Claire M, Varnier, Giulia, Gandhi, Akash, Radmore, Rebecca, Gupta, Vivek, Isenberg, David A, Jury, Elizabeth C, Ciurtin, Coziana

“…Similarities in the clinical and laboratory features of patients with primary Sjögren's syndrome (pSS) and systemic lupus erythematosus (SLE) have led to…”
Get full text